Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting
Not Applicable
Completed
- Conditions
- HealthyAnemia
- Interventions
- Device: Rad-67 Pulse oximeter & DCI Mini sensor
- Registration Number
- NCT04490863
- Lead Sponsor
- Masimo Corporation
- Brief Summary
The primary objective of this clinical investigation is to report on the repeatability and reproducibility of SpHb measurements from Rad-67 devices and DCI Mini sensors used to screen prospective blood donors at a donation center.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
- At least 18 years of age
- Weight at least 110 pounds
- Subjects with the intention of being screened for eligibility to donate blood
- The subject has given written informed consent to participate in the study
Exclusion Criteria
- Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
- Subjects unwilling to remove nail polish or acrylic nails
- Subjects with blood cancers such as leukemia
- Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia or with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
- Subjects with self-disclosed/known pregnancy at the time of enrollment
- Subjects deemed not suitable for the study at the discretion of the investigator
- Subjects unlikely to be able to refrain from excessive motion during data collection. Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Test subjects Rad-67 Pulse oximeter & DCI Mini sensor All subjects are enrolled and receive Rad-67 Pulse oximeter \& DCI Mini sensor for measurement of hemoglobin.
- Primary Outcome Measures
Name Time Method Coefficient of Variation of Rad-67 Approximately 90 minutes per subject Coefficient of variation will be computed using Repeatability and Reproducibility variance.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Blood Bank - Site 1
🇺🇸San Diego, California, United States